Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaДокументPhase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaДобавлено Shiro0 оценок0% нашли этот документ полезнымСохранить Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS Lymphoma на потом